// App-Quantinova.ai

TCT-104 : Efficacy and Safety of the NovaCross Microcatheter for Chronic Total Occlusions: An Expanded Safety Study

Researchers

Presenter

  • Simon Walsh

Principal Investigators

  • Dariusz Dudek

  • Dimitri Karmpaliotis

  • William Nicholson

  • Margaret McEntegart

  • James Spratt

  • Barry Uretsky

  • Paul Knaapen

  • Mark Goodwin

Medical Centers

  • nd Department of Cardiology Jagiellonian University Medical College, Cracow, Poland

  • Golden Jubilee National Hospital, Glasgow, Scotland, United Kingdom

  • University of Arkansas for Medical Sciences/Central Arkansas Veterans Healthcare System, Little Rock, Arkansas

  • Royal Victoria Hospital, Belfast, United Kingdom

  • York Hospital - Wellspan Health, York, Pennsylvania

  • NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York, USA

  • Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

  • St. George's University Hospital, London, United Kingdom

  • Edwards Hospital, Naperville, Illinois

Locations

  • Poland

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved